innovation for industry
Article | Micro-nanoelectronics
A unique interface between patients and the medical industry
Hub4aim has an unique proposal to manage the preindustrial
phase from the proof of concept to regulatory marking.
OWARD has been awarded a grant from the European Innovation Council (EIC) to support the development of an innovative Brain-Spine Interface technology for restoring mobility and upper limb function.
From January 11 to 14, 2021, the CEA will participate in the Consumer Electronic Show (CES) for the 7th consecutive year. For this 100% digital version, the CEA is supporting 3 startups spun off from its laboratories that have developed technological solutions in response to three major societal challenges: the energy transition, the digital transition and the medicine of the future.
GRENOBLE, France – October 7th, 2019 – For the first time, a tetraplegic patient was able to walk and control both arms using this neuroprosthetic, which records, transmits, and decodes brain signals in real-time to control an exoskeleton. The results of a clinical study under the Brain Computer Interface (BCI) Project at Clinatec were published on 4 October 2019 in The Lancet Neurology journal and provide proof of concept for controlling a four-limb exoskeleton. The system is driven via the long-term implant of a semi-invasive medical device to record brain activity developed at CEA in Grenoble. In the long term, this technology is expected to give greater mobility to individuals with severe motor disabilities.
The world's most influential tech event is back for another edition. For a new consecutive year, the CEA will be present at EUREKA PARK with a device including a technological innovation and 4 startups that allow to encompass three major transitions of the moment that are health, energy and digital. The CEA will also participate in CES UNVEILED LAS VEGAS on January 3, 2023 with the presence of the NIR demonstration and the startup Inocel. Meet the CEA at booth #60200 in Eureka Park!
Currently, labs require at least eight hours to determine the most efficient antibiotic treatment for a given infection. SUPPLY, a new research project at CEA-Leti, hopes to revolutionize this process thanks to a novel method of analysis based on “optical tweezers”. The project aims to create a prototype that could enable labs to confirm a treatment in only two hours.
Nano-biotechnology PlatformClinatec Platform
Connected Health ＆ WellnessAgriculture, Food Industry ＆ Environment
Smart Medical Technologies
See all demos
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.